FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051270132> ?p ?o ?g. }

• W2051270132 endingPage "856" @default.
• W2051270132 startingPage "849" @default.
• W2051270132 abstract "Abstract Reported rates of local failure after adjuvant radiation for women with inflammatory breast cancer (IBC) and triple-negative non-IBC are higher than those of women with receptor-expressing non-IBC. These high rates of locoregional recurrence are potentially influenced by the contribution of radioresistant cancer stem cells to these cancers. Statins have been shown to target stem cells and improve disease-free survival among IBC patients. We examined simvastatin radiosensitization of multiple subtypes of breast cancer cell lines in vitro in monolayer and mammosphere-based clonogenic assays and examined the therapeutic benefit of statin use on local control after postmastectomy radiation (PMRT) among IBC patients. We found that simvastatin radiosensitizes mammosphere-initiating cells (MICs) of IBC cell lines (MDA-IBC3, SUM149, SUM190) and of the metaplastic, non-IBC triple-negative receptor cell line (SUM159). However, simvastatin radioprotects MICs of non-IBC cell lines MCF-7 and SKBR3. In a retrospective clinical study of 519 IBC patients treated with PMRT, 53 patients used a statin. On univariate analysis, actuarial 3-year local recurrence-free survival (LRFS) was higher among statin users, and on multivariate analysis, triple negative breast cancer, absence of lymphatic invasion, neoadjuvant pathological tumor response to preoperative chemotherapy, and statin use were independently associated with higher LRFS. In conclusion, patients with IBC and triple-negative non-IBC breast cancer have the highest rates of local failure, and there are no available known radiosensitizers. We report significant improvement in local control after PMRT among statin users with IBC and significant radiosensitization across triple-negative and IBC cell lines of multiple subtypes using simvastatin. These data suggest that simvastatin should be justified as a radiosensitizing agent by a prospective clinical trial." @default.
• W2051270132 created "2016-06-24" @default.
• W2051270132 creator A5016731809 @default.
• W2051270132 creator A5018475755 @default.
• W2051270132 creator A5018617106 @default.
• W2051270132 creator A5022433974 @default.
• W2051270132 creator A5027475930 @default.
• W2051270132 creator A5045166646 @default.
• W2051270132 creator A5045529171 @default.
• W2051270132 creator A5047800296 @default.
• W2051270132 creator A5072420982 @default.
• W2051270132 creator A5075931431 @default.
• W2051270132 creator A5079305500 @default.
• W2051270132 creator A5087757550 @default.
• W2051270132 creator A5088814426 @default.
• W2051270132 date "2014-05-15" @default.
• W2051270132 modified "2023-10-15" @default.
• W2051270132 title "Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation" @default.
• W2051270132 cites W1967384627 @default.
• W2051270132 cites W1979658694 @default.
• W2051270132 cites W1980281602 @default.
• W2051270132 cites W1983357849 @default.
• W2051270132 cites W1992367938 @default.
• W2051270132 cites W1996053472 @default.
• W2051270132 cites W1996318057 @default.
• W2051270132 cites W2031579146 @default.
• W2051270132 cites W2036427463 @default.
• W2051270132 cites W2040380011 @default.
• W2051270132 cites W2043416876 @default.
• W2051270132 cites W2046389233 @default.
• W2051270132 cites W2049623935 @default.
• W2051270132 cites W2051248001 @default.
• W2051270132 cites W2052897104 @default.
• W2051270132 cites W2055498399 @default.
• W2051270132 cites W2065461844 @default.
• W2051270132 cites W2066122607 @default.
• W2051270132 cites W2072335004 @default.
• W2051270132 cites W2083094100 @default.
• W2051270132 cites W2086828029 @default.
• W2051270132 cites W2090539023 @default.
• W2051270132 cites W2105504936 @default.
• W2051270132 cites W2106986203 @default.
• W2051270132 cites W2113334910 @default.
• W2051270132 cites W2116876906 @default.
• W2051270132 cites W2117480880 @default.
• W2051270132 cites W2120656656 @default.
• W2051270132 cites W2125519401 @default.
• W2051270132 cites W2125711853 @default.
• W2051270132 cites W2127617517 @default.
• W2051270132 cites W2129732555 @default.
• W2051270132 cites W2134458879 @default.
• W2051270132 cites W2135994545 @default.
• W2051270132 cites W2141570734 @default.
• W2051270132 cites W2147602559 @default.
• W2051270132 cites W2153810797 @default.
• W2051270132 cites W2157981846 @default.
• W2051270132 cites W2158615473 @default.
• W2051270132 cites W2159640574 @default.
• W2051270132 cites W2163292580 @default.
• W2051270132 cites W2326317593 @default.
• W2051270132 cites W3140388327 @default.
• W2051270132 cites W4362223089 @default.
• W2051270132 doi "https://doi.org/10.5966/sctm.2013-0204" @default.
• W2051270132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4073823" @default.
• W2051270132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24833589" @default.
• W2051270132 hasPublicationYear "2014" @default.
• W2051270132 type Work @default.
• W2051270132 sameAs 2051270132 @default.
• W2051270132 citedByCount "63" @default.
• W2051270132 countsByYear W20512701322015 @default.
• W2051270132 countsByYear W20512701322016 @default.
• W2051270132 countsByYear W20512701322017 @default.
• W2051270132 countsByYear W20512701322018 @default.
• W2051270132 countsByYear W20512701322019 @default.
• W2051270132 countsByYear W20512701322020 @default.
• W2051270132 countsByYear W20512701322021 @default.
• W2051270132 countsByYear W20512701322022 @default.
• W2051270132 countsByYear W20512701322023 @default.
• W2051270132 crossrefType "journal-article" @default.
• W2051270132 hasAuthorship W2051270132A5016731809 @default.
• W2051270132 hasAuthorship W2051270132A5018475755 @default.
• W2051270132 hasAuthorship W2051270132A5018617106 @default.
• W2051270132 hasAuthorship W2051270132A5022433974 @default.
• W2051270132 hasAuthorship W2051270132A5027475930 @default.
• W2051270132 hasAuthorship W2051270132A5045166646 @default.
• W2051270132 hasAuthorship W2051270132A5045529171 @default.
• W2051270132 hasAuthorship W2051270132A5047800296 @default.
• W2051270132 hasAuthorship W2051270132A5072420982 @default.
• W2051270132 hasAuthorship W2051270132A5075931431 @default.
• W2051270132 hasAuthorship W2051270132A5079305500 @default.
• W2051270132 hasAuthorship W2051270132A5087757550 @default.
• W2051270132 hasAuthorship W2051270132A5088814426 @default.
• W2051270132 hasBestOaLocation W20512701321 @default.
• W2051270132 hasConcept C121608353 @default.
• W2051270132 hasConcept C126322002 @default.
• W2051270132 hasConcept C143998085 @default.
• W2051270132 hasConcept C2776329913 @default.
• W2051270132 hasConcept C2776839432 @default.

• next